2021
$21M
from 7 investors over 7 rounds
Vernal Biosciences raised $20M on June 27, 2023
Investors: Ampersand Capital Partners and VCET
Vernal Biosciences raised $21M on June 2, 2022
Investors: Ampersand Capital Partners, ATUM and Alloy Therapeutics, Inc
Vernal Biosciences raised undisclosed on July 12, 2021
Investors: VCET and Alloy Therapeutics, Inc